BiotechTube
HeartSine

HeartSine

Belfast, Ireland· Est.
heartsine.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $45M

Overview

HeartSine is a commercial-stage medical device company specializing in automated external defibrillators (AEDs). Its core innovation is the integrated Pad-Pak, a single-use cartridge combining the battery and electrodes with a unified four-year expiration date, simplifying maintenance and reducing the total cost of ownership. The company's devices feature proprietary SCOPE biphasic waveform technology, real-time CPR feedback, and integrated Wi-Fi connectivity for remote monitoring, positioning it as a key player in the public-access defibrillation market. As a subsidiary of Stryker, HeartSine leverages a global distribution network while maintaining its R&D and manufacturing operations in Belfast.

Cardiovascular

Technology Platform

SCOPE biphasic defibrillation waveform; Integrated Pad-Pak (battery+electrode cartridge); Wi-Fi connectivity for remote monitoring (HeartSine Gateway); Real-time CPR feedback.

Funding History

2
Total raised:$45M
Series B$30M
Series A$15M

Opportunities

Growth is driven by increasing legislative mandates for AED placement in public spaces and a growing emphasis on community emergency response.
Expansion into the home-use segment and emerging markets, facilitated by compact design and lower cost of ownership, presents significant new revenue channels.
The trend towards connected, smart medical devices aligns perfectly with HeartSine's Gateway platform, creating opportunities for value-added services and data analytics.

Risk Factors

The company operates in a highly competitive AED market with large, well-resourced competitors, pressuring pricing and innovation cycles.
As a medical device, it faces constant regulatory scrutiny and significant product liability exposure.
Strategic dependence on parent company Stryker means corporate priorities could shift, potentially impacting resource allocation for the HeartSine line.

Competitive Landscape

HeartSine competes in the global AED market against major players like Philips (HeartStart), ZOLL Medical (AED Plus, AED 3), and Physio-Control (LIFEPAK CR2). Its primary differentiators are the integrated Pad-Pak for simplified maintenance, compact form factor, and integrated connectivity. It must also navigate its position within Stryker's portfolio, which also includes the Physio-Control brand, requiring clear market segmentation.

More companies in Digital Health & Biotech SaaS →More companies in Ireland →